A TOLL-LIKE RECEPTOR 9 (TLR9) SINGLE NUCLEOTIDE POLYMORPHISM MAY INCREASE COMPLICATIONS TO HELICOBACTER PYLORI INFECTION

被引：0
|
作者：
Balogun, Rilwan
Ding, Lin
Mallick, Palash
Borgstrom, Mark
Gavini, Hemanth K.
Leal, Rolando J.
Taleban, Sasha
Babaria, Radhika
Merchant, Juanita L.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1251
引用
收藏
页码：S801 / S801
页数：1
相关论文
共 50 条
  • [41] Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis
    Holle, Julia U.
    Windmoeller, Mirca
    Lange, Christina
    Gross, Wolfgang L.
    Herlyn, Karen
    Csernok, Elena
    RHEUMATOLOGY, 2013, 52 (07) : 1183 - 1189
  • [42] Electronic Cigarettes Induce Mitochondrial DNA Damage and Trigger TLR9 (Toll-Like Receptor 9)-Mediated Atherosclerosis
    Li, Jieliang
    Huynh, Luong
    Cornwell, William D.
    Tang, Moon-Shong
    Simborio, Hannah
    Huang, Jing
    Kosmider, Beata
    Rogers, Thomas J.
    Zhao, Huanqing
    Steinberg, Michael B.
    Le, Le Thu Thi
    Zhang, Lanjing
    Kien Pham
    Liu, Chen
    Wang, He
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (02) : 839 - 853
  • [43] Single Nucleotide Polymorphisms of Toll-Like Receptor 7 and Toll-Like Receptor 9 in Hepatitis C Virus Infection Patients from Central China
    Wei, Xin-su
    Wei, Chuan-dong
    Tong, Yong-qing
    Zhu, Cheng-liang
    Zhang, Ping-an
    YONSEI MEDICAL JOURNAL, 2014, 55 (02) : 428 - 434
  • [44] Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis
    Zhi Chen
    Wei Wang
    Jianqin Liang
    Jinhe Wang
    Shisheng Feng
    Guangyu Zhang
    BMC Pulmonary Medicine, 15
  • [45] Toll-Like Receptor 9 (TLR9) Inhibition Attenuates Chronic Stress-Induced Social Behavior Deficits
    Jose, Dania
    Madeshiya, Amit Kumar
    Tripathi, Ashutosh
    Todd, Tela
    Quevedo, Joao
    Pillai, Anilkumar
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S180 - S180
  • [46] Toll-like receptor 9 (TLR9) activation by CpG or pDNA ameliorates hepatic fibrosis associated with lymphocyte alterations
    Axelrod, Jonathan H.
    Khvalevsky, Elena
    Doron, Sarit
    Enk, Jonathan
    Melhem, Alaa
    Nechemia, Yael
    Pappo, Orit
    Haj, Madi
    Galun, Eithan
    Safadi, Rifaat
    HEPATOLOGY, 2006, 44 (04) : 575A - 575A
  • [47] Selectively targeting the toll-like receptor 9 (TLR9) - IRF 7 signaling pathway by polymer blend particles
    Chen, Helen C.
    Zhan, Xi
    Tran, Kenny K.
    Shen, Hong
    BIOMATERIALS, 2013, 34 (27) : 6464 - 6472
  • [48] Toll-Like Receptor-9 (TLR9) is Requisite for Acute Inflammatory Response and Injury Following Lung Contusion
    Suresh, Madathilparambil V.
    Thomas, Bivin
    Dolgachev, Vladislav A.
    Sherman, Matthew A.
    Goldberg, Rebecca
    Johnson, Mark
    Chowdhury, Aulina
    Machado-Aranda, David
    Raghavendran, Krishnan
    SHOCK, 2016, 46 (04): : 412 - 419
  • [49] The role of toll-like receptor 9 (TLR9) in Epstein-Barr virus-associated gastric cancer
    Dworzanska, Anna
    Strycharz-Dudziak, Malgorzata
    Dworzanski, Jakub
    Stec, Agnieszka
    Rajtar, Barbara
    Drop, Bartlomiej
    Polz-Dacewicz, Malgorzata
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2020, 33 (02) : 106 - 111
  • [50] Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma
    Karime, Christian
    Wang, Jing
    Woodhead, Gregory
    Mody, Kabir
    Hennemeyer, Charles T.
    Borad, Mitesh J.
    Mahadevan, Daruka
    Chandana, Sreenivasa R.
    Babiker, Hani
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (01) : 1 - 13
12345